Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Rises as Complete Genomics, PacBio See Stocks Falter in March

NEW YORK (GenomeWeb News) – Vermillion's shares rose 51 percent for the month of March, leading all stocks in the GenomeWeb Daily News Index for the month.

The Austin, Texas-based molecular diagnostics firm received a late-month boost when it reported last week that its fourth-quarter revenues increased 152 percent year over year. Earlier in the month, it had announced that an American Medical Association panel approved its application for a Category 1 CPT code for its OVA1 test.

Among the other top performers for the month were Rosetta Genomics (+27 percent), which today reported a sharp drop in Fiscal Year 2011 revenues, and Exact Sciences (+19 percent).

Complete Genomics led decliners in the Index for the month, falling 24 percent. Early in the month, the firm reported a fourth-quarter revenue decline of 34 percent, but an order backlog of 5,800 genomes, representing total revenues of approximately $28 million.

The decline of Complete Genomics' share price followed a strong February, which saw its shares gain 26 percent.

Among the other firms to see a double-digit decline in their stock price were Pacific Biosciences, down 18 percent, and Accelr8, which fell 15 percent for the month.

Overall, the GWDN Index was up 2 percent for the month of March, matching the increase for the Dow Jones Industrial Average. The Nasdaq and Nasdaq Biotech Index both gained 4 percent for the month.


The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.